Clinical Trials Directory

Trials / Completed

CompletedNCT01611376

Impedance Cardiography During Major Abdominal Surgery

Comparison of Cardiac Output Derived From Flotrac/Vigileo and Impedance Cardiography During Major Abdominal Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Inje University · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators validated ICG's(impedance cardiography) usefulness during the abdominal surgery, by comparing it with FloTrac/Vigileo™ (Edwards Lifesciences,Irvine, CA, USA)

Detailed description

Intrathoracic structures have relatively constant resistance except the influence of changing diameter of aorta. Great vessels in thorax has the lowest resistance, and their diameter changes by the beats of the heart. As their diameter increases, their resistance decreases. ICG measures the difference between the resistances caused by heartbeats, and calculates cardiac output. But during the surgery, there are many interfering electrical currents made by electro cautery, patient positioning, and internal organ handling. Therefore, it has been thought that ICG is not a valid tool for measuring cardiac output during the surgery. The investigators validated ICG's usefulness during the surgery, by comparing it with Floctac/Vigileo.

Conditions

Interventions

TypeNameDescription
DEVICENiccomo™ (Medis, Ilmenau, Germany) impedance cardiography

Timeline

Start date
2012-09-01
Primary completion
2013-01-01
Completion
2013-02-01
First posted
2012-06-05
Last updated
2013-08-19

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01611376. Inclusion in this directory is not an endorsement.